andolast has been researched along with Asthma in 4 studies
*Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arshad, SH; D Amato, M; Giacovelli, G; Holgate, ST; Malerba, M; Radaeli, A; Rovati, L | 1 |
| Arshad, SH; D'Amato, M; Holgate, ST; Makovec, F; Persiani, S; Rovati, LC | 1 |
| Czuczwar, SJ; Gasior, M; Kleinrok, Z; Kozicka, M; Pietrasiewicz, T; Turski, WA | 1 |
| Colombo, S; Ferrari, F; Folco, G; Makovec, F; Revel, L; Rovati, LC | 1 |
2 trial(s) available for andolast and Asthma
| Article | Year |
|---|---|
Efficacy of Andolast in Mild to Moderate Asthma: A Randomized, Controlled, Double-Blind Multicenter Study (The Andast Trial).
Topics: Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Tetrazoles; Treatment Outcome; Young Adult | 2015 |
Pharmacokinetics of andolast after administration of single escalating doses by inhalation in mild asthmatic patients.
Topics: Administration, Inhalation; Anti-Allergic Agents; Asthma; Benzamides; Cross-Over Studies; Double-Blind Method; Humans; Tetrazoles | 2001 |
2 other study(ies) available for andolast and Asthma
| Article | Year |
|---|---|
Influence of a potential anti-asthmatic drug, CR 2039, upon the anticonvulsive activity of conventional antiepileptics against maximal electroshock-induced seizures in mice.
Topics: Animals; Anticonvulsants; Asthma; Avoidance Learning; Benzamides; Bronchodilator Agents; Carbamazepine; Drug Interactions; Electroshock; Epilepsy, Tonic-Clonic; Male; Memory; Mice; Phenytoin; Psychomotor Performance; Tetrazoles; Valproic Acid | 1996 |
CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the topical treatment of asthma.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Inhalation; Anaphylaxis; Animals; Asthma; Benzamides; Bronchoconstriction; Bronchodilator Agents; Capillary Permeability; Conjunctivitis, Allergic; Guinea Pigs; Histamine; Histamine Release; Male; Mast Cells; Passive Cutaneous Anaphylaxis; Rats; Rats, Sprague-Dawley; Respiratory System; Tetrazoles | 1992 |